Back to Journals » Therapeutics and Clinical Risk Management » Volume 3 » Issue 5

Once-daily MMX mesalamine for the treatment of mild-to-moderate ulcerative colitis

Total article views   HTML views PDF downloads Totals
4,733 Dovepress* 4,733+ 1,642 6,375
Totals 4,733 1,642 6,375
*Since 15 November 2007
+Since July 2016

View citations on Google Scholar